# Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials

> **NCT01063153** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 71 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Osmotic Release Methylphenidate

## Key facts

- **NCT ID:** NCT01063153
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063153, "Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01063153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*